









Markets
/
Stocks
/
nasdaq-antx
/

AN2 Therapeutics Inc

ANTX

1.141USD

+0.001+0.05%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

31.23MMarket Cap

LossP/E TTM



AN2 Therapeutics Inc

1.141

+0.001+0.05%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Total equity

Cash, cash equivalents and short-term investments

-39.82%62.92M

-41.28%67.06M

-22.07%83.62M

-24.55%93.43M

9.74%104.54M

29.03%114.21M

11.70%107.30M

18.62%123.82M

-15.99%95.26M

-25.21%88.52M

--96.06M

--104.38M

--113.39M

--118.35M

- Cash and cash equivalents

-31.94%18.22M

-19.07%19.98M

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

--27.22M

--28.80M

--40.62M

--82.52M

-Short-term investments

-42.53%44.70M

-47.41%47.08M

-32.06%62.27M

-34.30%59.92M

42.84%77.77M

44.84%89.52M

33.13%91.65M

20.67%91.20M

-25.18%54.45M

72.47%61.81M

--68.84M

--75.58M

--72.77M

--35.84M

Prepaid expenses

59.01%4.61M

18.83%2.50M

-17.68%2.64M

64.53%4.26M

-1.26%2.90M

19.02%2.10M

28.02%3.21M

-8.80%2.59M

-15.54%2.94M

26.49%1.77M

--2.51M

--2.84M

--3.48M

--1.40M

Other current assets

----

--0.00

----

-100.00%0.00

0.00%13.00K

6.25%34.00K

--53.00K

--73.00K

--13.00K

--32.00K

Total current assets

-37.15%67.52M

-40.20%69.56M

-21.94%86.26M

-22.72%97.69M

9.40%107.44M

28.78%116.31M

12.05%110.51M

17.81%126.41M

-15.97%98.21M

-24.60%90.32M

--98.62M

--107.30M

--116.88M

--119.78M

Non-current assets

Other non-current assets

-100.00%0.00

-70.85%304.00K

-22.91%804.00K

-100.00%0.00

44.86%1.04M

35.81%1.04M

44.86%1.04M

0.00%720.00K

6.67%768.00K

--720.00K

Total non-current assets

695.88%8.30M

138.20%11.78M

-79.37%5.83M

-100.00%0.00

44.86%1.04M

544.14%4.95M

616.86%28.24M

910.29%27.40M

-77.06%720.00K

6.67%768.00K

--3.94M

--2.71M

--3.14M

--720.00K

Total assets

-30.10%75.83M

-32.92%81.34M

-33.63%92.09M

-36.49%97.69M

9.66%108.48M

33.13%121.26M

35.28%138.74M

39.82%153.81M

-17.57%98.93M

-24.41%91.08M

--102.56M

--110.01M

--120.02M

--120.50M

Liabilities

Current liabilities

-Other payables

28.26%717.00K

14.95%369.00K

18.77%791.00K

31.04%1.27M

--559.00K

--321.00K

--666.00K

--973.00K

----

Accrued expenses

-45.95%4.15M

-42.19%4.57M

-42.70%6.13M

-21.76%7.03M

-4.13%7.68M

58.75%7.91M

113.77%10.70M

208.69%8.99M

218.65%8.01M

104.52%4.98M

--5.00M

--2.91M

--2.52M

--2.44M

Other current liabilities

28.26%717.00K

14.95%369.00K

18.77%791.00K

31.04%1.27M

--559.00K

--321.00K

--666.00K

--973.00K

----

Total current liabilities

-31.05%6.98M

-24.84%8.01M

-27.10%10.24M

-32.50%10.02M

-9.26%10.13M

24.48%10.66M

95.42%14.04M

234.81%14.84M

169.00%11.16M

68.39%8.57M

--7.19M

--4.43M

--4.15M

--5.09M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Derivatives liabilities

----

-100.00%0.00

-75.00%1.00K

-83.33%1.00K

--2.00K

--3.00K

--4.00K

--6.00K

Other non-current liabilities

----

--0.00

----

Total non-current liabilities

----

-100.00%0.00

-75.00%1.00K

-83.33%1.00K

--2.00K

--3.00K

--4.00K

--6.00K

Total liabilities

-31.05%6.98M

-24.84%8.01M

-27.10%10.24M

-32.50%10.02M

-9.27%10.13M

24.47%10.66M

95.37%14.04M

234.59%14.84M

168.77%11.16M

68.21%8.57M

--7.19M

--4.43M

--4.15M

--5.09M

Shareholders' equity

Common equity

2.75%291.70M

2.87%289.71M

3.12%287.59M

3.31%285.81M

36.01%283.89M

50.00%281.62M

50.37%278.88M

50.36%276.65M

14.21%208.73M

9.16%187.74M

--185.47M

--184.00M

--182.77M

--171.99M

Retained earnings

-20.15%-222.89M

-26.51%-216.43M

-33.23%-205.78M

-44.12%-198.25M

-53.50%-185.51M

-62.85%-171.07M

-72.15%-154.46M

-76.62%-137.56M

-81.61%-120.85M

-86.18%-105.05M

---89.72M

---77.88M

---66.54M

---56.42M

Capital reserves

2.75%291.70M

2.87%289.71M

3.12%287.59M

3.31%285.81M

36.01%283.89M

50.00%281.62M

50.37%278.88M

50.36%276.65M

14.21%208.73M

9.16%187.74M

--185.47M

--184.00M

--182.76M

--171.99M

Gains losses not affecting retained earnings

192.59%25.00K

-9.43%48.00K

-88.73%31.00K

191.80%112.00K

77.31%-27.00K

130.29%53.00K

173.53%275.00K

77.45%-122.00K

66.94%-119.00K

-10.76%-175.00K

---374.00K

---541.00K

---360.00K

---158.00K

Total equity

-30.01%68.84M

-33.70%73.33M

-34.36%81.85M

-36.91%87.67M

12.07%98.35M

34.03%110.60M

30.75%124.70M

31.63%138.97M

-24.25%87.76M

-28.50%82.52M

--95.37M

--105.57M

--115.86M

--115.41M

Currency unit

USD

Audit opinions

KeyAI

